NBRV - Nabriva Therapeutics EPS beats by $0.14 beats on revenue May, 06 2021 04:32 PM Nabriva Therapeutics plc Nabriva Therapeutics (NBRV): Q1 GAAP EPS of -$0.53 beats by $0.14.Revenue of $2.52M (+219.0% Y/Y) beats by $0.27M.Press Release For further details see: Nabriva Therapeutics EPS beats by $0.14, beats on revenue